David C Dale

Title: David C Dale: Innovator in Medical Treatments

Introduction

David C Dale is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of medicine, particularly in the treatment of severe neutropenia. With a total of 4 patents to his name, Dale's work has had a profound impact on patient care.

Latest Patents

One of his latest patents is a method of treating inherited severe neutropenia. This invention is directed to a method of treating severe neutropenia, specifically cyclic neutropenia (CN) or severe congenital neutropenia (SCN). The method involves administering a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof. Another notable patent is focused on methods to mobilize progenitor and stem cells. This patent discloses methods to elevate progenitor and stem cell counts in animal subjects using compounds that bind to the chemokine receptor CXCR4. Preferred embodiments of such compounds are of the formula Z-linker-Z'.

Career Highlights

Throughout his career, David C Dale has worked with notable companies such as Genzyme Corporation and Anormed, Inc. His experience in these organizations has allowed him to develop innovative solutions that address critical medical challenges.

Collaborations

Dale has collaborated with esteemed colleagues, including Gary James Bridger and Michael J Abrams. These partnerships have further enhanced his research and development efforts in the medical field.

Conclusion

David C Dale's contributions to medical innovation, particularly in the treatment of severe neutropenia, highlight his dedication to improving patient outcomes. His patents and collaborations reflect a commitment to advancing medical science and technology.